Led by endocrinologist specialist Dr Nicky Keay, MyFORM™ was developed to address the shortcomings of standard hormone testing which is confined to testing on a single day (in the case of perimenopause a single FSH test) and treats all women as having the same cycle length.
By combining scientific blood analysis taken on day 14 and 21 of your cycle and information about your unique cycle length, MyFORM™ mathematically maps how each of your four ovarian hormones fluctuate across your entire cycle not just on a single day.
Your report will indicate if your hormones are fluctuating in the normal pattern and identify if your ovarian response is in decline.
You’ll get a detailed, personalised report with next step actions from Forth’s expert endocrinologist, Dr Nicky Keay, who is also a member of the British Menopause Society. The report will tell you:
I was frustrated with the traditional approach of measuring a women’s hormones, which only provides data for hormone levels on a single day. As a clinician, I need to know how hormones fluctuate over the length of my patient’s personal cycle. That’s why I am very proud to have led the clinical development of MyFORM™ which is a significant breakthrough in empowering women with personalised information on their hormone health and improving the overall provision for women’s health.
Female hormones rise and fall significantly in a complex but characteristic pattern over the course of each women’s cycle. This hormone pattern is not only important for fertility but as hormones are integral to a number of systems in the body, they are essential to a women’s overall health and & wellbeing. The length of cycle, the timing of ovulation and the levels of each hormone will all vary from one woman to another making each woman’s pattern unique.
In the transition towards the menopause, a period known as the perimenopause, the two ovarian hormones oestrogen and progesterone start to decline, whilst the control hormone follicle-stimulating hormone (FSH) and luteinising hormone (LH) increase.
This phase can last 4-8 years and has a huge impact on a woman’s health and wellbeing including weaker bones and increased risk of heart disease. For some women a decline in ovarian function can also cause a range of symptoms including irregular periods, problems sleeping, hot flashes, low mood and hair loss.
Knowing when ovarian response is declining is therefore important so women can take action to make changes to their lifestyle and make decisions regarding treatment such as HRT.
Here are some of the most frequently asked questions. If you need anything else try our help section.
Female Hormone Mapping™ measures the four key female hormones. These are Oestradiol (the main form of Oestrogen), Progesterone, Follicular Stimulating Hormone (FSH) and Luteinising Hormone (LH).
The Female Hormone Mapping™ test is a double test kit which measures your fertility hormones at two points within the same cycle – day 14 and day 21. Once our lab has completed the analysis of both samples you’ll receive your personalised report via your secure dashboard.
No, our algorithm will adjust your curves to the length of your personal cycle, so it is important that you collect your samples as close to day 14 and 21 as possible, even if you have a longer or shorter than average cycle.
If your day 14 or 21 falls on a Friday, we recommend you collect your sample the day before. If your day 14 or 21 falls over the weekend, collect your sample on the following Monday and remember to post in a priority post box in time for that day’s collection.
Follicular Stimulating Hormone (FSH) and Luteinising Hormone (LH) are known as the control hormones and are produced by the pituitary gland. These hormones control the production of the ovarian response hormones, Oestradiol and Progesterone.
Oestradiol (the main form of Oestrogen) and Progesterone are ovarian response hormones which are produced by the ovaries. Their production is stimulated by the control hormones FSH and LH. If the control hormones are low, then the ovarian response hormones are also likely to be low. The exception to this is in later life (over 40) when the control hormones start to rise as ovarian responsiveness starts to decline i.e. the transition towards the menopause.
The Forth Ovarian Response Metric (FORM) is a unique and innovative evaluation of the functioning of the hormone network. This score takes into account all your hormone results rather than looking at any one in isolation. A score above 75 suggests a healthy ovarian response. Women over 40 can expect to see a decline in their ovarian response score as they enter the perimenopause and approach the menopause.
Female hormones, particularly the response hormones, have far reaching effects on a woman’s wellbeing. They are essential not only to the reproductive system but also the nervous system, musculoskeletal system, the digestive system, the cardiovascular system, the immune system and metabolism (that’s quite a list!). So you can see why healthy hormones are important throughout a woman’s life not only when wanting to start a family. In addition, the rise and fall of the ovarian hormones progesterone and oestradiol can influence how you feel throughout your cycle. Understanding how your hormones fluctuate can therefore help you to put strategies in place so you can feel at your best throughout your cycle as well as protecting your long term health.
Hormones can be influenced by lifestyle behaviours such as sleep, stress, nutrition and exercise. That’s why we give you tips and an action plan based on your results of the things you can do to improve your hormone levels and your quality of life.
Any hormonal contraception will mask your natural hormone levels. This product has been specifically designed for those who have naturally occurring cycles.
If you are on hormonal contraception or your cycle length is shorter than 22 days or longer than 40 days consistently over the past 6 months, or you aren’t currently having a period, then our Female Hormones test is best for you. If you are on the Copper Coil, you are able to take the Female Hormone Mapping test.